Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 13 May 2022 07:00 CEST |
NORDIC NANOVECTOR | Nordic Nanovector ASA: Results for the First Quarter 2022 | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 06 May 2022 15:35 CEST |
NORDIC NANOVECTOR | Nordic Nanovector ASA: Invitation to First Quarter 2022 Results Presentation and Webcast | 20103010 Biotechnology | Non-regulatory press releases |
| 03 May 2022 08:47 CEST |
NORDIC NANOVECTOR | Nordic Nanovector: New Publication Highlights Synergistic Potential of CD37-targeted Radioimmunoconjugate Humalutin® in Combination with the PARP-inhibitor Olaparib | 20103010 Biotechnology | Non-regulatory press releases |
| 28 Apr 2022 17:11 CEST |
NORDIC NANOVECTOR | Nordic Nanovector ASA: The Annual General Meeting held | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 Apr 2022 11:31 CEST |
NORDIC NANOVECTOR | Nordic Nanovector ASA - Notice of Annual General Meeting on 28 April 2022 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 Apr 2022 11:05 CEST |
NORDIC NANOVECTOR | Nordic Nanovector ASA publishes Annual Report 2021 | 20103010 Biotechnology | Annual financial and audit Reports |
| 06 Apr 2022 08:41 CEST |
NORDIC NANOVECTOR | Nordic Nanovector ASA Announces Proposed Board Changes - Former Algeta CEO Thomas Ramdahl nominated to Join Board of Directors | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Mar 2022 15:17 CET |
NORDIC NANOVECTOR | Nordic Nanovector ASA - Share capital increase registered | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Mar 2022 08:46 CET |
NORDIC NANOVECTOR | Nordic Nanovector ASA - Mandatory notification of trade - settlement of PSUs | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Mar 2022 10:38 CET |
NORDIC NANOVECTOR | Nordic Nanovector ASA - Share capital increase registered | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Mar 2022 10:09 CET |
NORDIC NANOVECTOR | Nordic Nanovector ASA - Final results of the subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Mar 2022 19:01 CET |
NORDIC NANOVECTOR | Nordic Nanovector ASA - Preliminary results of the subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Mar 2022 07:00 CET |
NORDIC NANOVECTOR | Nordic Nanovector ASA - allocation of PSUs | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Mar 2022 07:30 CET |
NORDIC NANOVECTOR | Nordic Nanovector Announces Presentation of Preclinical Data on Alpha37, at the American Association for Cancer Research 2022 Annual Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 01 Mar 2022 07:01 CET |
NORDIC NANOVECTOR | Nordic Nanovector ASA: Results for the Fourth Quarter and Full Year 2021 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 01 Mar 2022 07:00 CET |
NORDIC NANOVECTOR | Nordic Nanovector ASA: Resultat for fjerde kvartal og for helår 2021 | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 28 Feb 2022 08:00 CET |
NORDIC NANOVECTOR | Nordic Nanovector ASA - Commencement of the subscription period in the subsequent share offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 Feb 2022 14:11 CET |
NORDIC NANOVECTOR | Nordic Nanovector ASA: Prospectus approved | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 Feb 2022 12:00 CET |
NORDIC NANOVECTOR | Nordic Nanovector ASA - Resolution to increase the share capital in connection with the subsequent offering and terms of the subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Feb 2022 09:57 CET |
NORDIC NANOVECTOR | Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2021 Results Presentation and Webcast | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Feb 2022 10:13 CET |
NORDIC NANOVECTOR | Nordic Nanovector ASA: Extraordinary general meeting held | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 26 Jan 2022 10:38 CET |
NORDIC NANOVECTOR | Finansiell kalender | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 26 Jan 2022 10:38 CET |
NORDIC NANOVECTOR | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 Jan 2022 16:45 CET |
NORDIC NANOVECTOR | Nordic Nanovector ASA - Notice of extraordinary general meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Jan 2022 11:18 CET |
NORDIC NANOVECTOR | Nordic Nanovector ASA - Share capital increase registered | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 20 Jan 2022 08:43 CET |
NORDIC NANOVECTOR | Mandatory notification of trade | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 20 Jan 2022 07:00 CET |
NORDIC NANOVECTOR | Nordic Nanovector ASA - Ex subsequent offering today | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 19 Jan 2022 22:23 CET |
NORDIC NANOVECTOR | Nordic Nanovector ASA - Key information regarding potential subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 19 Jan 2022 22:20 CET |
NORDIC NANOVECTOR | Nordic Nanovector ASA - Private placement of new shares successfully placed | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 19 Jan 2022 16:57 CET |
NORDIC NANOVECTOR | Finansiell kalender | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 19 Jan 2022 16:57 CET |
NORDIC NANOVECTOR | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 19 Jan 2022 16:54 CET |
NORDIC NANOVECTOR | Nordic Nanovector ASA - Contemplated private placement of new shares | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 07 Jan 2022 19:22 CET |
NORDIC NANOVECTOR | Nordic Nanovector Provides update on PARADIGME, its Phase 2b Pivotal Trial with Betalutin® in R/R Follicular Lymphoma | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Dec 2021 09:39 CET |
NORDIC NANOVECTOR | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Dec 2021 09:39 CET |
NORDIC NANOVECTOR | Finansiell kalender | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 23 Dec 2021 07:30 CET |
NORDIC NANOVECTOR | Nordic Nanovector ASA: Financial Calendar for 2022 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Dec 2021 07:30 CET |
NORDIC NANOVECTOR | Nordic Nanovector appoints Experienced International Life Sciences Executive Sandra Jonsson as Chief Operating Officer | 20103010 Biotechnology | Non-regulatory press releases |
| 08 Dec 2021 16:30 CET |
NORDIC NANOVECTOR | Nordic Nanovector to Present at DNB's 12[th] Nordic Healthcare Conference | 20103010 Biotechnology | Non-regulatory press releases |
| 07 Dec 2021 07:30 CET |
NORDIC NANOVECTOR | Nordic Nanovector to present at 3rd Targeted Radiopharmaceutical Summit 2021 | 20103010 Biotechnology | Non-regulatory press releases |
| 30 Nov 2021 07:00 CET |
NORDIC NANOVECTOR | Nordic Nanovector R&D Day: Building Value from Betalutin® and a pipeline of broader therapeutic opportunities targeting CD37 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Nov 2021 08:00 CET |
NORDIC NANOVECTOR | Nordic Nanovector ASA: R&D Day to be virtual via live webcast only | 20103010 Biotechnology | Non-regulatory press releases |